HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

Prof Kaeberlein shares his path from CCTA soft plaque to starting Repatha

Gokhan Can · Jul 21, 2026 · ♥ 6 reactions · 0 comments · original Facebook post
PCSK9, ezetimibe & newer drugsPlaque, CAC & CT angiography
AI summary & key facts

Shares Matt Kaeberlein's video describing his heart-disease journey: coronary CT angiography showed early-stage soft plaque, he has a family history, and he started Repatha. Post gives only that outline.

Prof Kaeberlein's heart disease journey so far (CCTA -> early stage soft plaque + family history -> Repatha)

▶Video · YouTube · Matt KaeberleinWhy I Started Repatha (And Why I Almost Didn't)Why did I start taking Repatha? The answer isn't simply that my cholesterol was elevated—it was a heart scan that fundamentally changed how I thought about my cardiovascular risk. Last year I underwent a coronary CT angiography (CCTA) with contrast, a test that goes beyond a traditional calcium scan by allowing visualization of soft plaque, the type of…youtube.com
#plaque#repatha#heartdisease
← newer: Tweet and Novo Nordisk announcement shared without commentarolder: Merck's oral PCSK9 pill Lipfendra approved by FDA, cut LDL 5 →